Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
84.00
-1.15 (-1.35%)
Aug 12, 2026, 11:08 AM EDT - Market open
Globus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 535.43 | 537.87 | 102.98 | 122.87 | 190.17 | 149.19 |
Depreciation & Amortization | 279.91 | 276.84 | 253.39 | 145.53 | 68.25 | 69.87 |
Stock-Based Compensation | 48.96 | 49.78 | 54.19 | 52.74 | 32.81 | 30.59 |
Other Adjustments | 149.04 | -44.25 | 207.63 | 38.96 | -7.5 | 43.88 |
Change in Receivables | -99.79 | -52.18 | -78.06 | -49.91 | -50.84 | -25.9 |
Changes in Inventories | -50.43 | -17.6 | -29.86 | -70.33 | -61.75 | -11.97 |
Changes in Accounts Payable | 17.96 | 8.49 | 17.66 | -14.22 | 14.42 | 3.68 |
Changes in Accrued Expenses | 12.32 | 34.22 | 5.02 | 17.13 | 6.09 | 17.9 |
Changes in Income Taxes Payable | 7.16 | -50.85 | -13.38 | -0.41 | -2.89 | 5.21 |
Changes in Other Operating Activities | 9.82 | 11.13 | 1.06 | 1.15 | -10.29 | -6.18 |
Operating Cash Flow | 910.39 | 753.45 | 520.64 | 243.5 | 178.47 | 276.27 |
Operating Cash Flow Growth | 36.05% | 44.72% | 113.81% | 36.44% | -35.40% | 38.98% |
Capital Expenditures | -154.8 | -164.68 | -115.43 | -78.27 | -74.05 | -56.9 |
Purchases of Intangible Assets | - | -9.75 | - | - | - | - |
Purchases of Investments | -359.79 | -107.53 | -113.5 | -100.64 | -419.53 | -622.36 |
Proceeds from Sale of Investments | 21.48 | 179.49 | 70.52 | 777.91 | 414.65 | 337.81 |
Cash Acquisitions | -1.41 | -252.55 | -17.64 | -296.03 | -31.44 | -34.49 |
Investing Cash Flow | -499.01 | -355.01 | -176.05 | 302.97 | -110.36 | -375.94 |
Long-Term Debt Repaid | - | -449.99 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | -449.99 | - | - | - | - |
Issuance of Common Stock | 110.77 | 89.76 | 110.44 | 12.4 | 41.72 | 63.5 |
Repurchase of Common Stock | -224.47 | -303.36 | -92.52 | -236.18 | -144.49 | - |
Net Common Stock Issued (Repurchased) | -113.7 | -213.6 | 17.92 | -223.78 | -102.78 | 63.5 |
Other Financing Activities | -21.43 | -15.57 | -45.62 | -8.04 | -7.19 | -9.35 |
Financing Cash Flow | -135.13 | -679.16 | -27.7 | -231.82 | -109.96 | 54.15 |
Foreign Exchange Rate Adjustments | 2.05 | 22.45 | 0.26 | 2.18 | -0.75 | -0.81 |
Net Cash Flow | 278.3 | -258.28 | 317.15 | 316.83 | -42.6 | -46.33 |
Free Cash Flow | 755.59 | 588.77 | 405.21 | 165.23 | 104.42 | 219.38 |
Free Cash Flow Growth | 43.26% | 45.30% | 145.25% | 58.23% | -52.40% | 62.34% |
FCF Margin | 24.03% | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
Free Cash Flow Per Share | 5.52 | 4.30 | 2.94 | 1.44 | 1.02 | 2.12 |
Levered Free Cash Flow | 657.38 | 185.43 | 221.45 | 123.44 | 129.96 | 170.8 |
Unlevered Free Cash Flow | 640.68 | 524.08 | 260.07 | 99.48 | 118.16 | 163.81 |